| Title:
|
DEFINING OPTIMAL IMMUNOTHERAPIES FOR TYPE 1 DIABETES
|
| By: |
Novartis Foundation |
| Format: |
Other digital |
| List price:
|
£102.00 |
|
We currently do not stock this item, please contact the publisher directly for
further information.
|
|
|
|
|
|
| ISBN 10: |
0470697407 |
| ISBN 13: |
9780470697405 |
| Publisher: |
JOHN WILEY AND SONS LTD |
| Pub. date: |
13 August, 2008 |
| Series: |
Novartis Foundation Symposia 292 |
| Pages: |
222 |
| Description: |
* This book is a comprehensive and up-to-date account of where we stand in immunological strategies for preventing or treating type 1 diabetes (T1D). |
| Synopsis: |
* This book is a comprehensive and up-to-date account of where we stand in immunological strategies for preventing or treating type 1 diabetes (T1D).* Brings together contributions from the leaders in the arena of clinical immunotherapy, not limited to the diabetes field exclusively, in order to delineate a road-map that would lead to future clinical trials.* The book integrates information from human and animal studies.* The book considers T1D within the broader context of autoimmune disease.* The format contains several discussions, which address specific questions and provides guidelines for future strategies and solutions for discovering a cure. |
| Publication: |
US |
| Imprint: |
Wiley-Blackwell |
| Returns: |
Non-returnable |